NM_014671.3:c.689G>A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_014671.3(UBE3C):c.689G>A(p.Arg230Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000342 in 1,461,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014671.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE3C | NM_014671.3 | c.689G>A | p.Arg230Gln | missense_variant | Exon 7 of 23 | ENST00000348165.10 | NP_055486.2 | |
UBE3C | XM_047421072.1 | c.626G>A | p.Arg209Gln | missense_variant | Exon 7 of 23 | XP_047277028.1 | ||
UBE3C | XM_005249564.5 | c.614G>A | p.Arg205Gln | missense_variant | Exon 6 of 22 | XP_005249621.1 | ||
UBE3C | XM_047421073.1 | c.689G>A | p.Arg230Gln | missense_variant | Exon 7 of 16 | XP_047277029.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE3C | ENST00000348165.10 | c.689G>A | p.Arg230Gln | missense_variant | Exon 7 of 23 | 1 | NM_014671.3 | ENSP00000309198.8 | ||
UBE3C | ENST00000389103.4 | c.560G>A | p.Arg187Gln | missense_variant | Exon 5 of 9 | 5 | ENSP00000373755.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461362Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726966
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.689G>A (p.R230Q) alteration is located in exon 7 (coding exon 7) of the UBE3C gene. This alteration results from a G to A substitution at nucleotide position 689, causing the arginine (R) at amino acid position 230 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at